Urs Brändli
Chief Tech/Sci/R&D Officer bij DOTTIKON ES HOLDING AG
Vermogen: 1 M $ op 31-03-2024
Profiel
Urs Brändli is Hoofd-Processen & Technologieën bij Dottikon Es Holding AG.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DOTTIKON ES HOLDING AG
0.03% | 31-03-2023 | 4 050 ( 0.03% ) | 1 M $ | 31-03-2024 |
Actieve functies van Urs Brändli
| Bedrijven | Functie | Begin |
|---|---|---|
| DOTTIKON ES HOLDING AG | Chief Tech/Sci/R&D Officer | 01-01-2003 |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - |
| Dottikon Es Management AG | Corporate Officer/Principal | - |
Swiss Chemical Society
 Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DOTTIKON ES HOLDING AG | Process Industries |
| Bedrijven in privébezit | 3 |
|---|---|
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Commercial Services |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
| Dottikon Es Management AG |
